Year in review 2007: Critical Care - Shock

Critical Care

Volumn 12, Issue 5, 2008, Pages

  Wagner, Florian ^a   Baumgart, Katja ^a   Simkova, Vladislava ^b   Georgieff, Michael ^a   Radermacher, Peter ^a   Calzia, Enrico ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; CHOLECYSTOKININ; ERYTHROPOIETIN; INTERLEUKIN 10; INTERLEUKIN 8; NITRIC OXIDE SYNTHASE INHIBITOR; PEPTIDE YY; PETHIDINE;

ACID BASE BALANCE; BLOOD FLOW; BODY SURFACE; BURN PATIENT; COLLOID; CRITICAL ILLNESS; CRYSTALLOID; DRUG EFFICACY; FLUID RESUSCITATION; GASTROINTESTINAL MOTILITY; HEMODYNAMICS; HEMORRHAGIC SHOCK; HUMAN; HYPERTHERMIC THERAPY; HYPOTHERMIA; INTENSIVE CARE; LEUKOCYTE ADHERENCE; LOW DRUG DOSE; METABOLIC ACIDOSIS; MICROCIRCULATION; NONHUMAN; ORGAN INJURY; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; REPERFUSION; REVIEW; SEPTIC SHOCK; SHIVERING; STOMACH EMPTYING; VASOCONSTRICTION; WARMING; ANIMAL; METHODOLOGY; SHOCK;

ANIMALS; CRITICAL CARE; CRITICAL ILLNESS; HUMANS; SHOCK;

EID: 55049136267     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc6949     Document Type: Review

References (58)

1. Delmas A Leone M Rousseau S Albanese J Martin C Clinical review: vasopressin and terlipressin in septic shock patients Crit Care 2005, 9:212-222. 1175907 15774080 10.1186/cc2945
2. Russell JA Walley KR Singer J Gordon AC Hebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008, 358:877-887. 10.1056/NEJMoa067373 18305265
3. Bracht H Asfar P Radermacher P Calzia E Vasopressin in vasodilatory shock: Hemodynamic stabilization at the cost of the liver and the kidney? [Review] Crit Care 2007, 11:178. 2246204 18177510 10.1186/cc6171
4. Krejci V Hiltebrand LB Jakob SM Takala J Sigurdsson GH Vasopressin in septic shock: Effects on pancreatic, renal, and hepatic blood flow Crit Care 2007, 11:R129. 2246226 18078508 10.1186/cc6197
5. Hiltebrand LB Krejci V Jakob SM Takala J Sigurdsson GH Effects of vasopressin on microcirculatory blood flow in the gastrointestinal tract in anesthetized pigs in septic shock Anesthesiology 2007, 106:1156-1167. 10.1097/01.anes.0000267599.02140.86 17525591
6. Asfar P Hauser B Ivanyi Z Ehrmann U Kick J Albicini M Vogt J Wachter U Bruckner UB Radermacher P Bracht H Low-dose terlipressin during long-term hyperdynamic porcine endotoxemia: Effects on hepatosplanchnic perfusion, oxygen exchange, and metabolism Crit Care Med 2005, 33:373-380. 10.1097/01.CCM.0000152253.45901.FB 15699842
7. Sun Q Dimopoulos G Nguyen DN Tu Z Nagy N Hoang AD Rogiers P De Backer D Vincent JL Low-dose vasopressin in the treatment of septic shock in sheep Am J Respir Crit Care Med 2003, 168:481-486. 10.1164/ rccm.200205-447OC 12791578
8. Russell JA Vasopressin in septic shock Crit Care Med 2007, 35:S609-S615. 10.1097/01.CCM.0000279158.51481.41 17713417
9. Kwan I Bunn F Roberts I Timing and volume of fluid administration for patients with bleeding Cochrane Database Syst Rev 2003, 3:CD002245. 12917926
10. Roberts I Alderson P Bunn F Chinnock P Ker K Schierhout G Colloids versus crystalloids for fluid resuscitation in critically ill patients Cochrane Database Syst Rev 2004, 18:CD000567. 15495001
11. Raedler C Voelckel WG Wenzel V Krismer AC Schmittinger CA Herff H Mayr VD Stadlbauer KH Lindner KH Konigsrainer A Treatment of uncontrolled hemorrhagic shock after liver trauma: Fatal effects of fluid resuscitation versus improved outcome after vasopressin Anesth Analg 2004, 98:1759-1766. 10.1213/01.ANE.0000117150.29361.5A 15155342
12. Sharma RM Setlur R Vasopressin in hemorrhagic shock Anesth Analg 2005, 101:833-834. 10.1213/01.ANE.0000175209.61051.7F 16116000
13. Voelckel WG Raedler C Wenzel V Lindner KH Krismer AC Schmittinger CA Herff H Rheinberger K Konigsrainer A Arginine vasopressin, but not epinephrine, improves survival in uncontrolled hemorrhagic shock after liver trauma in pigs Crit Care Med 2003, 31:1160-1165. 10.1097/ 01.CCM.0000060014.75282.69 12682488
14. Stadlbauer KH Wagner-Berger HG Krismer AC Voelckel WG Konigsrainer A Lindner KH Wenzel V Vasopressin improves survival in a porcine model of abdominal vascular injury Crit Care 2007, 11:R81. 2206489 17659093 10.1186/cc5977
15. Meybohm P Cavus E Bein B Steinfath M Weber B Hamann C Scholz J Dorges V Small volume resuscitation: A randomized controlled trial with either norepinephrine or vasopressin during severe hemorrhage J Trauma 2007, 62:640-646. 17414341
16. Silver M Corwin MJ Bazan A Gettinger A Enny C Corwin HL Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: A randomized, double-blind, placebo-controlled trial Crit Care Med 2006, 34:2310-2316. 10.1097/ 01.CCM.0000233873.17954.42 16878035
17. Corwin HL Gettinger A Fabian TC May A Pearl RG Heard S An R Bowers PJ Burton P Klausner MA Corwin MJ Efficacy and safety of epoetin alfa in critically ill patients N Engl J Med 2007, 357:965-976. 10.1056/ NEJMoa071533 17804841
18. Coleman T Brines M Science review: Recombinant human erythropoietin in critical illness: A role beyond anemia? Crit Care 2004, 8:337-341. 1065012 15469595 10.1186/cc2897
19. Thiemermann C Beneficial effects of erythropoietin in preclinical models of shock and organ failure Crit Care 2007, 11:132. 2206404 17543134 10.1186/cc5912
20. Ehrenreich H Hasselblatt M Dembowski C Cepek L Lewczuk P Stiefel M Rustenbeck HH Breiter N Jacob S Knerlich F Bohn M Poser W Ruther E Kochen M Gefeller O Gleiter C Wessel TC De Ryck M Itri L Prange H Cerami A Brines M Siren AL Erythropoietin therapy for acute stroke is both safe and beneficial Mol Med 2002, 8:495-505. 2040012 12435860
21. Simon F Scheuerle A Calzia E Bassi G Öter F Nguyen Duy C Kick J Brückner UB Radermacher P Schelzig H Erythropoietin during porcine aortic balloon-occlusion-induced ischemia/reperfusion injury Crit Care Med 2008, 36:2143-2150. 18552697
22. Kao R Xenocostas A Rui T Yu P Huang W Rose J Martin CM Erythropoietin improves skeletal muscle microcirculation and tissue bioenergetics in a mouse sepsis model Crit Care 2007, 11:R58. 2206412 17509156 10.1186/ cc5920
23. Maiese K Li F Chong ZZ New avenues of exploration for erythropoietin JAMA 2005, 293:90-95. 2254180 15632341 10.1001/jama.293.1.90
24. Bateman RM Sharpe MD Ellis CG Bench-to-bedside review: Microvascular dysfunction in sepsis - hemodynamics, oxygen transport, and nitric oxide Crit Care 2003, 7:359-373. 270719 12974969 10.1186/cc2353
25. Hauser B Matejovic M Radermacher P Nitric oxide, leukocytes and microvascular permeability: Causality or bystanders? Crit Care 2008, 12:104. 2374610 18226179 10.1186/cc6214
26. Groeneveld AB Sipkema P Interaction of oxyradicals, antioxidants, and nitric oxide during sepsis Crit Care Med 2000, 28:2161-2162. 10.1097/ 00003246-200006000-00098 10890696
27. Matejovic M Krouzecky A Martinkova V Rokyta R Jr Kralova H Treska V Radermacher P Novak I Selective inducible nitric oxide synthase inhibition during long-term hyperdynamic porcine bacteremia Shock 2004, 21:458-465. 10.1097/00024382-200405000-00010 15087823
28. Hollenberg SM Broussard M Osman J Parrillo JE Increased microvascular reactivity and improved mortality in septic mice lacking inducible nitric oxide synthase Circ Res 2000, 86:774-778. 10764411
29. Hollenberg SM Guglielmi M Parrillo JE Discordance between microvascular permeability and leukocyte dynamics in septic inducible nitric oxide synthase deficient mice Crit Care 2007, 11:R125. 2246221 18062823 10.1186/cc6190
30. Forni LG McKinnon W Hilton PJ Unmeasured anions in metabolic acidosis: unravelling the mystery Crit Care 2006, 10:220. 1750972 16879718 10.1186/ cc4954
31. Bruegger D Kemming GI Jacob M Meisner FG Wojtczyk CJ Packert KB Keipert PE Faithfull NS Habler OP Becker BF Rehm M Causes of metabolic acidosis in canine hemorrhagic shock: Role of unmeasured ions Crit Care 2007, 11:R130. 2246228 18081930 10.1186/cc6200
32. Kellum JA Clinical review: Reunification of acid-base physiology Crit Care 2005, 9:500-507. 1297616 16277739 10.1186/cc3789
33. Bowling FG Morgan TJ Krebs cycle anions in metabolic acidosis Crit Care 2005, 9:E23. 1297638 16277707 10.1186/cc3878
34. Gunnerson KJ Saul M He S Kellum JA Lactate versus non-lactate metabolic acidosis: A retrospective outcome evaluation of critically ill patients Crit Care 2006, 10:R22. 1550830 16507145 10.1186/cc3987
35. Protti A Singer M Bench-to-bedside review: Potential strategies to protect or reverse mitochondrial dysfunction in sepsis-induced organ failure Crit Care 2006, 10:228. 1751057 16953900 10.1186/cc5014
36. Alam HB Chen Z Li Y Velmahos G Demoya M Keller CE Toruno K Mehrani T Rhee P Spaniolas K Profound hypothermia is superior to ultraprofound hypothermia in improving survival in a swine model of lethal injuries Surgery 2006, 140:307-314. 10.1016/j.surg.2006.03.015 16904984
37. Morrison M Blackwood JE Lockett SL Iwata A Winn RK Roth MB Surviving blood loss using hydrogen sulfide J Trauma 2008, 65:183-188. 18580516
38. Morgan TJ The meaning of acid-base abnormalities in the intensive care unit: Part III - effects of fluid administration Crit Care 2005, 9:204-211. 1175908 15774079 10.1186/cc2946
39. Deane A Chapman MJ Fraser RJ Bryant LK Burgstad C Nguyen NQ Mechanisms underlying feed intolerance in the critically ill: Implications for treatment World J Gastroenterol 2007, 13:3909-3917. 17663503
40. Nguyen NQ Ng MP Chapman M Fraser RJ Holloway RH The impact of admission diagnosis on gastric emptying in critically ill patients Crit Care 2007, 11:R16. 2151889 17288616 10.1186/cc5685
41. Fruhwald S Holzer P Metzler H Intestinal motility disturbances in intensive care patients pathogenesis and clinical impact Intensive Care Med 2007, 33:36-44. 10.1007/s00134-006-0452-7 17115132
42. Chapman MJ Nguyen NQ Fraser RJ Gastrointestinal motility and prokinetics in the critically ill Curr Opin Crit Care 2007, 13:187-194. 10.1097/ MCC.0b013e3280523a88 17327741
43. Nguyen NQ Fraser RJ Bryant LK Chapman MJ Wishart J Holloway RH Butler R Horowitz M The relationship between gastric emptying, plasma cholecystokinin, and peptide YY in critically ill patients Crit Care 2007, 11:R132. 2246231 18154642 10.1186/cc6205
44. Nguyen NQ Fraser RJ Chapman MJ Bryant LK Holloway RH Vozzo R Wishart J Feinle-Bisset C Horowitz M Feed intolerance in critical illness is associated with increased basal and nutrient-stimulated plasma cholecystokinin concentrations Crit Care Med 2007, 35:82-88. 10.1097/ 01.CCM.0000250317.10791.6C 17095943
45. Artinian V Krayem H DiGiovine B Effects of early enteral feeding on the outcome of critically ill mechanically ventilated medical patients Chest 2006, 129:960-967. 10.1378/chest.129.4.960 16608945
46. 2 breath tests for investigating gastrointestinal functions Food Nutr Bull 2002, 23:166-168. 12362787
47. McGwin G Jr George RL Cross JM Rue LW Improving the ability to predict mortality among burn patients Burns 2008, 34:320-327. 10.1016/ j.burns.2007.06.003 17869427
48. Jeschke MG Mlcak RP Finnerty CC Norbury WB Gauglitz GG Kulp GA Herndon DN Burn size determines the inflammatory and hypermetabolic response Crit Care 2007, 11:R90. 2206482 17716366 10.1186/cc6102
49. American Thoracic Society Evidence-based colloid use in the critically ill: American Thoracic Society Consensus Statement Am J Respir Crit Care Med 2004, 170:1247-1259. 10.1164/rccm.200208-909ST 15563641
50. Gombocz K Beledi A Alotti N Kecskes G Gabor V Bogar L Koszegi T Garai J Influence of dextran-70 on systemic inflammatory response and myocardial ischaemia-reperfusion following cardiac operations Crit Care 2007, 11:R87. 2206488 17697359 10.1186/cc6095
51. Kamler M Pizanis N Hagl S Gebhard MM Jakob H Extracorporal-circulation-induced leukocyte/endothelial cell interaction is inhibited by dextran Clin Hemorheol Microcirc 2004, 31:139-148. 15310949
52. Schuerholz T Marx G Dextran-70 to modulate inflammatory response after cardiopulmonary bypass: Potential for a novel approach? Crit Care 2007, 11:163. 2556734 17850682 10.1186/cc6103
53. Bernard S New indications for the use of therapeutic hypothermia Crit Care 2004, 8:E1. 1065078 15609426 10.1186/cc2994
54. Polderman KH Application of therapeutic hypothermia in the ICU: opportunities and pitfalls of a promising treatment modality. Part 1: indications and evidence Intensive Care Med 2004, 30:556-575. 10.1007/ s00134-003-2152-x 14767591
55. Polderman KH Application of therapeutic hypothermia in the intensive care unit. Opportunities and pitfalls of a promising treatment modality - Part 2: Practical aspects and side effects Intensive Care Med 2004, 30:757-769. 10.1007/s00134-003-2151-y 14767590
56. Hoedemaekers CW Ezzahti M Gerritsen A Hoeven van der JG Comparison of cooling methods to induce and maintain normo- and hypothermia in intensive care unit patients: A prospective intervention study Crit Care 2007, 11:R91. 2206487 17718920 10.1186/cc6104
57. Piper SN Maleck WH Boldt J Suttner SW Schmidt CC Reich DG A comparison of urapidil, clonidine, meperidine and placebo in preventing postanesthetic shivering Anesth Analg 2000, 90:954-957. 10.1097/ 00000539-200004000-00033 10735806
58. Kimberger O Ali SZ Markstaller M Zmoos S Lauber R Hunkeler C Kurz A Meperidine and skin surface warming additively reduce the shivering threshold: A volunteer study Crit Care 2007, 11:R29. 2151895 17316456 10.1186/cc5709